MarketPeel
Insider Trading Intelligence
Pricing
…
TC

Todd Alfred Carter

VYGR
CHIEF SCIENTIFIC OFFICER · VOYAGER THERAPEUTICS, INC. · CIK 0001944011
FILING MIX · LIFETIME39%/61%
BUYS
12
SELLS
19
TOTAL VALUE
$339.0K
COMPANIES
1
ACTIVE SINCE
Sep 2022
HOLDINGS NOW
145,718
AVG SELL PX
$6.58
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Todd Alfred Carter, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+41.18%+5.05%+0.02%+5.03%-0.22%—
14d17+41.18%+6.88%+0.26%+6.62%+0.95%—
30d17+41.18%+2.31%-0.09%+2.39%+5.57%—
60d17+52.94%+0.47%-0.27%+0.75%-1.73%—
90d17+41.18%+5.37%+3.46%+2.21%+2.82%—
180d17(3 pending)+42.86%+1.92%+11.71%-9.79%-10.99%—
1y17(3 pending)+78.57%-15.07%+22.71%-37.78%-39.20%—
2y17(6 pending)+100.00%-46.79%+49.06%-95.86%-97.00%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VYGR · 145,718 shares · as of Feb 24, 2026
041,25082,500123,750165,0002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 12 buys / 19 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,174$3.76$15.7K145,718Feb 24, 2026Feb 26, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,301$3.44$11.4K149,892Feb 18, 2026Feb 20, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,525$3.85$13.6K153,193Feb 10, 2026Feb 11, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,000——156,718Feb 6, 2026Feb 10, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
154,000——154,000Feb 6, 2026Feb 10, 2026 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
46,000——123,718Feb 21, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
92,000——92,000Feb 21, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,305$4.26$14.1K77,718Feb 20, 2025Feb 24, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,413$4.45$24.1K81,023Feb 11, 2025Feb 12, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,191$5.13$6.1K86,436Jan 14, 2025Jan 15, 2025 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,365$7.47$25.1K87,627Feb 21, 2024Feb 22, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
602$7.68$4.6K90,992Feb 20, 2024Feb 22, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
77,000——77,000Feb 9, 2024Feb 16, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,500——91,594Feb 9, 2024Feb 16, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,266$7.18$9.1K53,094Jan 17, 2024Jan 19, 2024 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,000$2.85$14.3K64,860Sep 15, 2023Sep 18, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,500$8.16$85.7K54,360Sep 15, 2023Sep 18, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,000——40,000Sep 15, 2023Sep 18, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
5,000$2.85$14.3K70,360Jun 30, 2023Jul 5, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
5,000——45,000Jun 30, 2023Jul 5, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$11.41$57.0K65,360Jun 30, 2023Jul 5, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,193$7.76$17.0K65,360Mar 20, 2023Mar 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,000——68,291Feb 17, 2023Feb 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
68,000——68,000Feb 17, 2023Feb 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
738$7.45$5.5K67,553Feb 17, 2023Feb 22, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
797$7.67$6.1K34,291Feb 13, 2023Feb 15, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$10.34$4.1K35,088Jan 17, 2023Jan 19, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
706$9.57$6.8K35,488Jan 17, 2023Jan 19, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
Chief Scientific Officer
388$6.41$2.5K36,194Jan 6, 2023Jan 10, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
388$5.17$2.0K36,582Dec 31, 2022Jan 10, 2023 ↗View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
165,000——165,000Sep 19, 2022Sep 21, 2022 ↗View →
Other insiders · VYGR
Loading peer insiders…
About this filer
CIK 0001944011
ROLE
Chief Scientific Officer
PRIMARY
VYGR
COMPANIES
1
ACTIVE SINCE
Sep 2022
MARKETPEEL · /INSIDER/0001944011DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback